Allergan's much-maligned tribal licensing deal wins reprieve at appeals court | FiercePharma
Allergan settles Restasis litigation with Pfizer's InnoPharma as backlash mounts over tribal patent deal | FiercePharma
7. Restasis | FiercePharma
Restasis: Why US consumers paid billions for drug deemed ineffective in other countries
In a New Twist in Restasis Legal Battle, Teva Sues the FDA
Allergan loses Restasis patent protections in federal court decision | FiercePharma
Teva Has Earned Nothing,' US FDA Tells Court In Battle Over Generic Restasis 180-Day Exclusivity :: Pink Sheet
Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents - TheStreet
FDA Approvals - Big Molecule Watch | Big Molecule Watch
FAQ | Restasis® (Cyclosporine Ophthalmic Emulsion)
Court throws out Allergan's patent deal with Native American tribe - PMLiVE
Xiidra vs. Restasis: Differences, similarities, and which is better for you
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease
Buy Restasis from Canada Cloud Pharmacy, the most trusted Canadian Pharmacy
FDA Set To Make Key Decision On Restasis Generics :: Generics Bulletin
Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents :: Pink Sheet
Allergan heads to federal court to defend Restasis against early generic rivals | FiercePharma
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease
Allergan, Inc. v. Teva Pharms.: Federal Court Invalidates Allergan Patents as Obvious - Harvard Journal of Law & Technology
Retailers File Lawsuit Against Allergan over Restasis Patents | BioSpace
Restasis Update: Generic (Teva) available in Canada – When in the US? – Mauger Bloggers
Www restasis not rx
8. Restasis | FiercePharma
Allergan's Restasis Will Soon be Open to Generic Copycats After Ruling in Patent Case - Xtalks
Teva's Generic Restasis Could Punish Allergan (NYSE:AGN) | Seeking Alpha
